4-aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero

Maternal-fetal exchange of a potent tobacco-related human carcinogen, 4-aminobiphenyl, was studied in smoking (n = 14) and nonsmoking (n = 38) pregnant women. N-Hydroxy-4-aminobiphenyl, the active metabolite of 4-aminobiphenyl, forms chemical addition products (adducts) with hemoglobin. Levels of 4-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JNCI : Journal of the National Cancer Institute 1991-02, Vol.83 (4), p.274-280
Hauptverfasser: COGHLIN, J, GANN, P. H, HAMMOND, S. K, SKIPPER, P. L, TAGHIZADEH, K, PAUL, M, TANNENBAUM, S. R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 280
container_issue 4
container_start_page 274
container_title JNCI : Journal of the National Cancer Institute
container_volume 83
creator COGHLIN, J
GANN, P. H
HAMMOND, S. K
SKIPPER, P. L
TAGHIZADEH, K
PAUL, M
TANNENBAUM, S. R
description Maternal-fetal exchange of a potent tobacco-related human carcinogen, 4-aminobiphenyl, was studied in smoking (n = 14) and nonsmoking (n = 38) pregnant women. N-Hydroxy-4-aminobiphenyl, the active metabolite of 4-aminobiphenyl, forms chemical addition products (adducts) with hemoglobin. Levels of 4-aminobiphenyl hemoglobin adducts were measured in maternal-fetal paired blood samples obtained from smoking and nonsmoking women during labor and delivery. Carcinogen-hemoglobin adducts were detected in all maternal and fetal blood samples. Levels of such adducts were significantly higher (P less than .001) in maternal and fetal blood samples from smokers: the mean 4-aminobiphenyl hemoglobin adduct level was 92 +/- 54 pg/g of hemoglobin in blood samples from fetuses of smokers, and 17 +/- 13 pg/g of hemoglobin in blood samples from fetuses of nonsmokers; the mean maternal 4-aminobiphenyl hemoglobin adduct level was 183 +/- 108 pg/g of hemoglobin in smokers, and 22 +/- 8 pg/g of hemoglobin in nonsmokers. Fetal carcinogen-adduct levels were consistently lower than maternal levels: the mean maternal to fetal ratio was 2.4 +/- 1.1 in smokers and 1.9 +/- .98 in nonsmokers. Fetal 4-aminobiphenyl hemoglobin adduct levels were strongly associated (correlation coefficient [r2] = .51, P = .002) with maternal 4-aminobiphenyl hemoglobin adduct levels when paired samples from smoking mothers were analyzed. A measure of third-trimester tobacco smoke exposure based on number of cigarettes smoked per day, amount of each cigarette smoked, and depth of inhalation was associated (r2 = .59, P = .029) with maternal 4-aminobiphenyl levels but not with fetal 4-aminobiphenyl levels. This study demonstrates that a potent tobacco-related carcinogen, 4-aminobiphenyl, or its active metabolite, N-hydroxy-4-aminobiphenyl, crosses the human placenta and binds to fetal hemoglobin in concentrations that are significantly higher in smokers than in nonsmokers.
format Article
fullrecord <record><control><sourceid>pubmed_pasca</sourceid><recordid>TN_cdi_pubmed_primary_1994056</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1994056</sourcerecordid><originalsourceid>FETCH-LOGICAL-p826-6316bee69f3f57e0daefafa5ed1cecaa454d8d87975d65f0bb57afce338911683</originalsourceid><addsrcrecordid>eNo9j81LxDAQxYMoa139E4QcvBaSNp9HWfyCBS97dpkmk221bUrTgvvfW7E4lzeP38yDd0EyLhTLC87kJckYK3RujBbX5CalT7aMLcSGbLi1gkmVkQ-RQ9f0sWqGGvtzS2vs4qldfE_B-9lNiS5rwGlOmCh-DzGhp1OkU42LVOBcpKmLX0gdjG6JOmH_-zJPOMZbchWgTXi36pYcnp8Ou9d8__7ytnvc54MpVK5KripEZUMZpEbmAQMEkOi5QwcgpPDGG2219EoGVlVSQ3BYlsZyrky5Jfd_scNcdeiPw9h0MJ6Pa82FP6wckoM2jNC7Jv2fCaustkX5A70CXnE</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>4-aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero</title><source>Oxford University Press Journals Digital Archive legacy</source><source>MEDLINE</source><creator>COGHLIN, J ; GANN, P. H ; HAMMOND, S. K ; SKIPPER, P. L ; TAGHIZADEH, K ; PAUL, M ; TANNENBAUM, S. R</creator><creatorcontrib>COGHLIN, J ; GANN, P. H ; HAMMOND, S. K ; SKIPPER, P. L ; TAGHIZADEH, K ; PAUL, M ; TANNENBAUM, S. R</creatorcontrib><description>Maternal-fetal exchange of a potent tobacco-related human carcinogen, 4-aminobiphenyl, was studied in smoking (n = 14) and nonsmoking (n = 38) pregnant women. N-Hydroxy-4-aminobiphenyl, the active metabolite of 4-aminobiphenyl, forms chemical addition products (adducts) with hemoglobin. Levels of 4-aminobiphenyl hemoglobin adducts were measured in maternal-fetal paired blood samples obtained from smoking and nonsmoking women during labor and delivery. Carcinogen-hemoglobin adducts were detected in all maternal and fetal blood samples. Levels of such adducts were significantly higher (P less than .001) in maternal and fetal blood samples from smokers: the mean 4-aminobiphenyl hemoglobin adduct level was 92 +/- 54 pg/g of hemoglobin in blood samples from fetuses of smokers, and 17 +/- 13 pg/g of hemoglobin in blood samples from fetuses of nonsmokers; the mean maternal 4-aminobiphenyl hemoglobin adduct level was 183 +/- 108 pg/g of hemoglobin in smokers, and 22 +/- 8 pg/g of hemoglobin in nonsmokers. Fetal carcinogen-adduct levels were consistently lower than maternal levels: the mean maternal to fetal ratio was 2.4 +/- 1.1 in smokers and 1.9 +/- .98 in nonsmokers. Fetal 4-aminobiphenyl hemoglobin adduct levels were strongly associated (correlation coefficient [r2] = .51, P = .002) with maternal 4-aminobiphenyl hemoglobin adduct levels when paired samples from smoking mothers were analyzed. A measure of third-trimester tobacco smoke exposure based on number of cigarettes smoked per day, amount of each cigarette smoked, and depth of inhalation was associated (r2 = .59, P = .029) with maternal 4-aminobiphenyl levels but not with fetal 4-aminobiphenyl levels. This study demonstrates that a potent tobacco-related carcinogen, 4-aminobiphenyl, or its active metabolite, N-hydroxy-4-aminobiphenyl, crosses the human placenta and binds to fetal hemoglobin in concentrations that are significantly higher in smokers than in nonsmokers.</description><identifier>ISSN: 0027-8874</identifier><identifier>EISSN: 1460-2105</identifier><identifier>PMID: 1994056</identifier><language>eng</language><publisher>Cary, NC: Oxford University Press</publisher><subject>Aminobiphenyl Compounds - blood ; Aminobiphenyl Compounds - metabolism ; Aminobiphenyl Compounds - pharmacokinetics ; Biological and medical sciences ; Carcinogens - metabolism ; Carcinogens - pharmacokinetics ; Dose-Response Relationship, Drug ; Female ; Fetus - metabolism ; Hemoglobins - metabolism ; Humans ; Maternal-Fetal Exchange ; Medical sciences ; Nicotiana ; Plants, Toxic ; Pregnancy - blood ; Prenatal Exposure Delayed Effects ; Smoke - adverse effects ; Tobacco, tobacco smoking ; Toxicology</subject><ispartof>JNCI : Journal of the National Cancer Institute, 1991-02, Vol.83 (4), p.274-280</ispartof><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4969792$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1994056$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>COGHLIN, J</creatorcontrib><creatorcontrib>GANN, P. H</creatorcontrib><creatorcontrib>HAMMOND, S. K</creatorcontrib><creatorcontrib>SKIPPER, P. L</creatorcontrib><creatorcontrib>TAGHIZADEH, K</creatorcontrib><creatorcontrib>PAUL, M</creatorcontrib><creatorcontrib>TANNENBAUM, S. R</creatorcontrib><title>4-aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero</title><title>JNCI : Journal of the National Cancer Institute</title><addtitle>J Natl Cancer Inst</addtitle><description>Maternal-fetal exchange of a potent tobacco-related human carcinogen, 4-aminobiphenyl, was studied in smoking (n = 14) and nonsmoking (n = 38) pregnant women. N-Hydroxy-4-aminobiphenyl, the active metabolite of 4-aminobiphenyl, forms chemical addition products (adducts) with hemoglobin. Levels of 4-aminobiphenyl hemoglobin adducts were measured in maternal-fetal paired blood samples obtained from smoking and nonsmoking women during labor and delivery. Carcinogen-hemoglobin adducts were detected in all maternal and fetal blood samples. Levels of such adducts were significantly higher (P less than .001) in maternal and fetal blood samples from smokers: the mean 4-aminobiphenyl hemoglobin adduct level was 92 +/- 54 pg/g of hemoglobin in blood samples from fetuses of smokers, and 17 +/- 13 pg/g of hemoglobin in blood samples from fetuses of nonsmokers; the mean maternal 4-aminobiphenyl hemoglobin adduct level was 183 +/- 108 pg/g of hemoglobin in smokers, and 22 +/- 8 pg/g of hemoglobin in nonsmokers. Fetal carcinogen-adduct levels were consistently lower than maternal levels: the mean maternal to fetal ratio was 2.4 +/- 1.1 in smokers and 1.9 +/- .98 in nonsmokers. Fetal 4-aminobiphenyl hemoglobin adduct levels were strongly associated (correlation coefficient [r2] = .51, P = .002) with maternal 4-aminobiphenyl hemoglobin adduct levels when paired samples from smoking mothers were analyzed. A measure of third-trimester tobacco smoke exposure based on number of cigarettes smoked per day, amount of each cigarette smoked, and depth of inhalation was associated (r2 = .59, P = .029) with maternal 4-aminobiphenyl levels but not with fetal 4-aminobiphenyl levels. This study demonstrates that a potent tobacco-related carcinogen, 4-aminobiphenyl, or its active metabolite, N-hydroxy-4-aminobiphenyl, crosses the human placenta and binds to fetal hemoglobin in concentrations that are significantly higher in smokers than in nonsmokers.</description><subject>Aminobiphenyl Compounds - blood</subject><subject>Aminobiphenyl Compounds - metabolism</subject><subject>Aminobiphenyl Compounds - pharmacokinetics</subject><subject>Biological and medical sciences</subject><subject>Carcinogens - metabolism</subject><subject>Carcinogens - pharmacokinetics</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>Fetus - metabolism</subject><subject>Hemoglobins - metabolism</subject><subject>Humans</subject><subject>Maternal-Fetal Exchange</subject><subject>Medical sciences</subject><subject>Nicotiana</subject><subject>Plants, Toxic</subject><subject>Pregnancy - blood</subject><subject>Prenatal Exposure Delayed Effects</subject><subject>Smoke - adverse effects</subject><subject>Tobacco, tobacco smoking</subject><subject>Toxicology</subject><issn>0027-8874</issn><issn>1460-2105</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9j81LxDAQxYMoa139E4QcvBaSNp9HWfyCBS97dpkmk221bUrTgvvfW7E4lzeP38yDd0EyLhTLC87kJckYK3RujBbX5CalT7aMLcSGbLi1gkmVkQ-RQ9f0sWqGGvtzS2vs4qldfE_B-9lNiS5rwGlOmCh-DzGhp1OkU42LVOBcpKmLX0gdjG6JOmH_-zJPOMZbchWgTXi36pYcnp8Ou9d8__7ytnvc54MpVK5KripEZUMZpEbmAQMEkOi5QwcgpPDGG2219EoGVlVSQ3BYlsZyrky5Jfd_scNcdeiPw9h0MJ6Pa82FP6wckoM2jNC7Jv2fCaustkX5A70CXnE</recordid><startdate>19910220</startdate><enddate>19910220</enddate><creator>COGHLIN, J</creator><creator>GANN, P. H</creator><creator>HAMMOND, S. K</creator><creator>SKIPPER, P. L</creator><creator>TAGHIZADEH, K</creator><creator>PAUL, M</creator><creator>TANNENBAUM, S. R</creator><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>19910220</creationdate><title>4-aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero</title><author>COGHLIN, J ; GANN, P. H ; HAMMOND, S. K ; SKIPPER, P. L ; TAGHIZADEH, K ; PAUL, M ; TANNENBAUM, S. R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p826-6316bee69f3f57e0daefafa5ed1cecaa454d8d87975d65f0bb57afce338911683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Aminobiphenyl Compounds - blood</topic><topic>Aminobiphenyl Compounds - metabolism</topic><topic>Aminobiphenyl Compounds - pharmacokinetics</topic><topic>Biological and medical sciences</topic><topic>Carcinogens - metabolism</topic><topic>Carcinogens - pharmacokinetics</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>Fetus - metabolism</topic><topic>Hemoglobins - metabolism</topic><topic>Humans</topic><topic>Maternal-Fetal Exchange</topic><topic>Medical sciences</topic><topic>Nicotiana</topic><topic>Plants, Toxic</topic><topic>Pregnancy - blood</topic><topic>Prenatal Exposure Delayed Effects</topic><topic>Smoke - adverse effects</topic><topic>Tobacco, tobacco smoking</topic><topic>Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>COGHLIN, J</creatorcontrib><creatorcontrib>GANN, P. H</creatorcontrib><creatorcontrib>HAMMOND, S. K</creatorcontrib><creatorcontrib>SKIPPER, P. L</creatorcontrib><creatorcontrib>TAGHIZADEH, K</creatorcontrib><creatorcontrib>PAUL, M</creatorcontrib><creatorcontrib>TANNENBAUM, S. R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>JNCI : Journal of the National Cancer Institute</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>COGHLIN, J</au><au>GANN, P. H</au><au>HAMMOND, S. K</au><au>SKIPPER, P. L</au><au>TAGHIZADEH, K</au><au>PAUL, M</au><au>TANNENBAUM, S. R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>4-aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero</atitle><jtitle>JNCI : Journal of the National Cancer Institute</jtitle><addtitle>J Natl Cancer Inst</addtitle><date>1991-02-20</date><risdate>1991</risdate><volume>83</volume><issue>4</issue><spage>274</spage><epage>280</epage><pages>274-280</pages><issn>0027-8874</issn><eissn>1460-2105</eissn><abstract>Maternal-fetal exchange of a potent tobacco-related human carcinogen, 4-aminobiphenyl, was studied in smoking (n = 14) and nonsmoking (n = 38) pregnant women. N-Hydroxy-4-aminobiphenyl, the active metabolite of 4-aminobiphenyl, forms chemical addition products (adducts) with hemoglobin. Levels of 4-aminobiphenyl hemoglobin adducts were measured in maternal-fetal paired blood samples obtained from smoking and nonsmoking women during labor and delivery. Carcinogen-hemoglobin adducts were detected in all maternal and fetal blood samples. Levels of such adducts were significantly higher (P less than .001) in maternal and fetal blood samples from smokers: the mean 4-aminobiphenyl hemoglobin adduct level was 92 +/- 54 pg/g of hemoglobin in blood samples from fetuses of smokers, and 17 +/- 13 pg/g of hemoglobin in blood samples from fetuses of nonsmokers; the mean maternal 4-aminobiphenyl hemoglobin adduct level was 183 +/- 108 pg/g of hemoglobin in smokers, and 22 +/- 8 pg/g of hemoglobin in nonsmokers. Fetal carcinogen-adduct levels were consistently lower than maternal levels: the mean maternal to fetal ratio was 2.4 +/- 1.1 in smokers and 1.9 +/- .98 in nonsmokers. Fetal 4-aminobiphenyl hemoglobin adduct levels were strongly associated (correlation coefficient [r2] = .51, P = .002) with maternal 4-aminobiphenyl hemoglobin adduct levels when paired samples from smoking mothers were analyzed. A measure of third-trimester tobacco smoke exposure based on number of cigarettes smoked per day, amount of each cigarette smoked, and depth of inhalation was associated (r2 = .59, P = .029) with maternal 4-aminobiphenyl levels but not with fetal 4-aminobiphenyl levels. This study demonstrates that a potent tobacco-related carcinogen, 4-aminobiphenyl, or its active metabolite, N-hydroxy-4-aminobiphenyl, crosses the human placenta and binds to fetal hemoglobin in concentrations that are significantly higher in smokers than in nonsmokers.</abstract><cop>Cary, NC</cop><pub>Oxford University Press</pub><pmid>1994056</pmid><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0027-8874
ispartof JNCI : Journal of the National Cancer Institute, 1991-02, Vol.83 (4), p.274-280
issn 0027-8874
1460-2105
language eng
recordid cdi_pubmed_primary_1994056
source Oxford University Press Journals Digital Archive legacy; MEDLINE
subjects Aminobiphenyl Compounds - blood
Aminobiphenyl Compounds - metabolism
Aminobiphenyl Compounds - pharmacokinetics
Biological and medical sciences
Carcinogens - metabolism
Carcinogens - pharmacokinetics
Dose-Response Relationship, Drug
Female
Fetus - metabolism
Hemoglobins - metabolism
Humans
Maternal-Fetal Exchange
Medical sciences
Nicotiana
Plants, Toxic
Pregnancy - blood
Prenatal Exposure Delayed Effects
Smoke - adverse effects
Tobacco, tobacco smoking
Toxicology
title 4-aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T10%3A34%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=4-aminobiphenyl%20hemoglobin%20adducts%20in%20fetuses%20exposed%20to%20the%20tobacco%20smoke%20carcinogen%20in%20utero&rft.jtitle=JNCI%20:%20Journal%20of%20the%20National%20Cancer%20Institute&rft.au=COGHLIN,%20J&rft.date=1991-02-20&rft.volume=83&rft.issue=4&rft.spage=274&rft.epage=280&rft.pages=274-280&rft.issn=0027-8874&rft.eissn=1460-2105&rft_id=info:doi/&rft_dat=%3Cpubmed_pasca%3E1994056%3C/pubmed_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/1994056&rfr_iscdi=true